A new collaboration has been established between the Laboratory of Cellular and Molecular Oncology, headed by Prof. Giorgio Stassi, at the Department of Surgical, Oncological and Oral Sciences (DICHIRONS), University of Palermo and the National Institutes of Health (NIH), Bethesda, Maryland, USA. The strenght of this scientific collaboration between DICHIRONS and the NIH is confirmed by the following points:
- Published papers in collaboration with Dr. Ettore Appella, Chief of Chemical Immunology Section, Laboratory of Cell Biology, National Cancer Institute (NCI), and Dr. Carol J. Thiele, Deputy Director of Center for Cancer Research and Deputy Chief of the Pediatric Oncology Branch, at NIH.
- DICHIRONS is provided with a “Special Volunteer” agreement with the NIH in the years 2016-2018.
- Expertise in TP53, stem cell biology and molecular oncology fields is integrated in these two laboratories.
The outcome of the ongoing cooperation is a scientific project based on the role of TP53 in cancer stem cells freshly isolated from patients affected by colorectal cancer (CRC). This project is aimed to develop novel therapies as a precision medicine approach in the oncology field.[pdf-embedder url=”https://www.cmol.it/wp-content/uploads/2018/10/SPV-Agreement.pdf” title=”SPV Agreement”]